Miomira Ivovic

Miomira Ivovic

Auto-generated profile, based on publicly available information

Miomira Ivovic

Faculty of Medicine, National Center for Infertility and Endocrinology of Gender, Clinic of Endocrinology, Diabetes and Diseases of Metabolism, University Clinical Center, University of Belgrade, 11000 Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2013
Verified
Journal Article
Closed access
SVSvetlana Vujović
Svetlana Vujović
MIMiomira Ivović
Miomira Ivović
MTMilina Tancić-Gajić
Milina Tancić-Gajić
LMLjiljana Marina
Ljiljana Marina
MBMarija Barać
Marija Barać
DMDragan Micić
Dragan Micić

1 April 2023 in Endocrines
Verified
Journal Article
Open access
PDF file
SPSvetlana Jovicic Pavlovic
Svetlana Jovicic Pavlovic
MIMiomira Ivović
Miomira Ivović
MTMilina Tancic-Gajic
Milina Tancic-Gajic
LMLjiljiana V. Marina
Ljiljiana V. Marina
SPSvetlana Jovicic Pavlovic
Svetlana Jovicic Pavlovic
MJMilena M Eric Jovicic
Milena M Eric Jovicic
Estradiol promotes neuronal growth, transmission, survival, myelinization, plasticity, synaptogenesis, and dendritic branching and it improves cognitive function. Alzheimer’s disease (AD) is characterized by amyloid plaques, neurofibrillary tangles, and the loss of neuronal connection in the brain. Genomic analysis has concluded that hypoestrogenism influences the APOE gene and increases the risk of AD. Premature ovarian insufficiency (POI) is defined as oligo/amenorrhea in women below 40 years of age, low estradiol, and high-gonadotropin levels. Early symptoms and signs of POI must be detected in time in order to prevent subsequent complications, such as Alzheimer’s disease. Meta-analysis has shown favorable effects of estrogen in preventing Alzheimer’s. We measured some of the typical markers of AD in women with POI such as interleukin 6 (IL-6), interleukin 8 (IL-8), tissue necrosis factor α (TNFα), TAU1, TREM2, and amyloid precursor proteins (APP). While FSH, LH, and IL-8 were significantly higher in POI group, compared to controls, testosterone and DHEAS were lower. A significant decrease in IL-6 was found in the POI group during a 6-month therapy, as well as an increase in amyloid precursor proteins. CONCLUSION: Neurological complications of POI, such as declining short-term memory, cognitive function, and dementia, have to be promptly stopped by initiating estro-progestogen therapy in POI. A long-term continuation of the therapy would be strongly advised.

31 January 2018
Verified
Book Chapter
Closed access
PDF file
SVSvetlana Vujović
Svetlana Vujović
MTMilina Tancic-Gajic
Milina Tancic-Gajic
LMLjiljana Marina
Ljiljana Marina
ZAZorana Arizanovic
Zorana Arizanovic
ZSZorana Stojanovic
Zorana Stojanovic
MIMiomira Ivovic
Miomira Ivovic

1 January 2007 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
ZPZorana Penezic
Zorana Penezic
MZMilos Zarkovic
Milos Zarkovic
SVSvetlana Vujovic
Svetlana Vujovic
MIMiomira Ivovic
Miomira Ivovic
BBBiljana Beleslin
Biljana Beleslin
MDMilka Drezgic
Milka Drezgic
Introduction: Diagnosis and differential diagnosis of Cushing?s syndrome (CS) remain considerable challenge in endocrinology. For more than 20 years, CRH has been widely used as differential diagnostic test. Following the CRH administration, the majority of patients with ACTH secreting pituitary adenoma show a significant rise of plasma cortisol and ACTH, whereas those with ectopic ACTH secretion characteristically do not. Objective The aim of our study was to assess the value of CRF test for differential diagnosis of CS using the ROC (receiver operating characteristic) curve method. Method A total of 30 patients with CS verified by pathological examination and postoperative testing were evaluated. CRH test was performed within diagnostic procedures. ACTH secreting pituitary adenoma was found in 18, ectopic ACTH secretion in 3 and cortisol secreting adrenal adenoma in 9 of all patients with CS. Cortisol and ACTH were determined -15, 0, 15, 30, 45, 60, 90 and 120 min. after i.v. administration of 100?g of ovine CRH. Cortisol and ACTH were determined by commercial RIA. Statistical data processing was done by ROC curve analysis. Due to small number, the patients with ectopic ACTH secretion were excluded from test evaluation by ROC curve method. Results In evaluated subgroups, basal cortisol was (1147.3?464.3 vs. 1589.8?296.3 vs. 839.2?405.6 nmol/L); maximal stimulated cortisol (1680.3?735.5 vs. 1749.0?386.6 vs. 906.1?335.0 nmol/L); and maximal increase as a percent of basal cortisol (49.1?36.9 vs. 9.0?7.6 vs. 16.7?37.3 %). Consequently, basal ACTH was (100.9 ?85.0 vs. 138.0?123.7 vs. 4.8?4.3 pg/mL) and maximal stimulated ACTH (203.8 ?160.1 vs. 288.0?189.5 vs. 7.4?9.2 pg/mL). For cortisol, determination area under ROC curve was 0.815?0.083 (CI 95% 0.652-0.978). For cortisol increase cut-off level of 20%, test sensitivity was 83%, with specificity of 78%. For ACTH, determination area under ROC curve was 0.637?0.142 (CI 95% 0.359-0.916). For ACTH increase cut-off level of 30%, test sensitivity was 70%, with specificity of 57%. Conclusion Determination of cortisol and ACTH levels in CRH test remains reliable tool in differential diagnosis of Cushing?s syndrome.

1 July 2015
Verified
Journal Article
Closed access
MTMilina Tancic-Gajic
Milina Tancic-Gajic
SVSvetlana Vujović
Svetlana Vujović
IDIrena Dujmović
Irena Dujmović
IBIvana Basta
Ivana Basta
MIMiomira Ivović
Miomira Ivović
DMDragan Micić
Dragan Micić

17 April 2014 in Endocrine Abstracts
Verified
Journal Article
Closed access
MIMiomira Ivovic
Miomira Ivovic
LMLjiljana Marina
Ljiljana Marina
SVSvetlana Vujovic
Svetlana Vujovic
MTMilina Tancic-Gajic
Milina Tancic-Gajic
ZAZorana Arizanovic
Zorana Arizanovic
DMDragan Micic
Dragan Micic
Introduction: Primary thyroid lymphoma (PTL) presents between 2 and 8% of all thyroid malignancies. Rapidly enlarging neck mass, especially in women with Hashimoto’s thyroiditis should steer the diagnostic procedures in the way of PTL. The most common type is diffuse large B-cell lymphoma. Adrenal incidentaloma are incidentally discovered adrenal masses without prior suspicion of adrenal disease. Case report: A 71-year-old woman with an adrenal incidentaloma was admitted to our Clinic for regular annual testing. Her incidentaloma was first diagnosed 3 years ago. Ultrasound and CT confirmed left adrenal tumor of 15 mm in size. Annual endocrine evaluations showed normal midnight cortisol and basal ACTH with adequate cortisol suppression after 1 mg-overnight dexamethason suppresion test. Plasma renin activity (PRA) and aldosterone (ALD) were also in normal range with normal ALD:PRA ratio. Normal urinary catecholamines and serum chromogranine excluded active pheochromocythoma. Annual CT visualizations showed no change in tumor size during these 3 years. For the last 7 years she was taking levothyroxine due to hypothyroidism – Hashimoto’s thyroiditis. Her thyroid status showed good substitution with elevated antithyroglobulin and anti-thyroid peroxidase antibodies. Ultrasound revealed recently enlarged thyroid mass with normal calcitonine. Surgery was performed after fine needle cytology. Pathohistology and immunohistochemistry showed B-cell lymphoma positive for CD3, CD5, CD43, PAX5, CD20 and partially positive for bcl2, CD43, with Ki67 of 25%. After surgery she received six cycles of chemotherapy. Overall she is doing well with good prognostic features. Conclusion: The adrenal tumor was diagnosed three years before PTL and it did not show any change in size so it is most unlikely that this incidentaloma was of B cell lymphoma origin. According to the available literature this is the first case of PTL in a patient with most likely benign, nonfunctional adrenal incidentaloma.